Navigation Links
Eisai Inc. and the Alzheimer's Association Announce the Winner of the C.A.R.E. Pharmacy Award
Date:11/24/2008

WOODCLIFF LAKE, N.J., Nov. 24 /PRNewswire/ -- Eisai Inc., in coordination with the Alzheimer's Association, announced today the recipient of the C.A.R.E. (Commitment to Alzheimer's. Recognition of Excellence.) Pharmacy Award. The C.A.R.E. Pharmacy Award acknowledges a pharmacist who has been nominated by a person with Alzheimer's disease or a caregiver for his or her exceptional impact on the lives of those fighting this disease. The award was established to recognize the critical role that pharmacists play in supporting people with Alzheimer's disease and their families.

The C.A.R.E. Pharmacy Award is a reflection of the Eisai human health care (hhc) mission, which regards patients and their families as the most important participants in the health care process. Eisai is proud to be in its eighth year of recognizing a pharmacist for this accomplishment and is excited to have been joined by the Alzheimer's Association for the 2008 award.

The recipient of the 2008 C.A.R.E. Pharmacy Award is Tracey Pierce, RPh, CGP, FASCP. Tracey is a clinical pharmacist with Blanchard Valley Hospital in Findlay, Ohio, and a preceptor and associate clinical professor at Ohio Northern University Raabe College of Pharmacy. She donates countless hours each year conducting family education programs and consultations at health fairs. As an educator, she encourages her students to also participate in these programs. As expressed in her nomination, "Tracey is a true patient advocate."

(Photo: http://www.newscom.com/cgi-bin/prnh/20081124/NYM026 )

"Alzheimer's is a disease that affects both patients and their caregivers. Eisai's commitment to the patient and caregiver communities is unwavering, and community pharmacists play an integral role in each patient's treatment and care, through ongoing monitoring, counseling and s
'/>"/>

SOURCE Eisai Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
2. U.S. District Court Decision About Eisais Legal Action Over Aricept ODT(R) ANDA Filing
3. Eisai Announces Change in U.S. Submission Schedule for E7389 New Drug Application
4. Eisai/Pfizers Aricept Owns a Dominating 42.4% Patient Share for First-Line Treatment of Alzheimers Disease
5. Eisai is Granted Favorable Preliminary Injunction Ruling in Aricept(R) Patent Infringement Lawsuit Against Teva Pharmaceuticals
6. Eisai Corporation of North America Announces Appointment of Cynthia Schwalm as President, Eisai Inc.
7. Eisai Receives Action Letter on Fospropofol Disodium Injection for Sedation in Diagnostic or Therapeutic Procedures
8. TorreyPines Therapeutics Sells Alzheimers Disease Genetics Program to Eisai
9. Allegiance Equity Corporation announces collaboration with Canadian Dairy Commission and Guelph Food Technologies Corporation for Alzheimers and Dementia formulation GG-XT
10. Diagenic Partners With DNAVision to Offer First Breast Cancer and Alzheimers Gene-Expression Blood Tests
11. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...v. 24 Sigma-Aldrich Corp... NASDAQ OMX conference on Tuesday, December 1st at... parties may listen via live audio broadcast over ...g m a a ldrich.com/ . Users can click the "W...Sigma-Aldrich: Sigma-Aldrich is a leading Life S...
(Date:11/24/2009)... REYKJAVIK, Iceland, November 24 /PRNewswire-First...ay announced the approval of all of its,"first day...trict of Delaware,(the "Bankruptcy Court"). deCODE...nder Chapter 11 of the United States Bankruptcy Co...s issued by the Bankruptcy Court allow the company...
(Date:11/24/2009)...alif., Nov. 24 NeurogesX...ny focused on developing and commercializing novel...nthony DiTonno, President and Chief Executive Offi...per Jaffray Health Care Conference, to be held Dec...w York, New York. ,, Mr. DiTonno and Stephen G...
(Date:11/24/2009)... Blue Marble Energy Corp. announce...elopment Authority (OPDA) were recently awarded $2...Revitalization Board (CERB) in a private/public pa... biochemical biorefinery in Lincoln County, WA. ...e development of our biorefinery and bring over 70...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
...er 15 Agendia BV, world leader in the,rapidly evo...day that it,has acquired the rights to the discove...ently-used breast cancer drug Herceptin(R), which ...l "Cancer Cell". The antibody drug Herceptin(R) t...about one in four breast cancers and the HER2 prot...
...ct. 15 The U.S. Food and Drug,Administration (FDA...n) as,a new treatment for complicated intra-abdomi...uding pyelonephritis. DORIBAX has demonstrated,act... Gram-negative(2),bacteria -- including Pseudomona... belongs to a class of antibacterial agents called...
...15 /PRNewswire-FirstCall/ - Neptune Technologies &....V.NTB), is pleased to,announce the appointment of...isory Board"), comprised of 5 renowned scientists.... experience of the new,members of the Advisory Boa...ntifically driven growth. Neptune feels privileged...
Other Biology Technology:Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test 2FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections 2FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections 3FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections 4FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections 5Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board 2Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board 3
(Date:11/26/2009)...t Staphylococcus Aureus ) and other drug-resistan...ure plasma prototype devices have been developed t...al cocktails. , Two prototype devices have been ...hy skin (e.g. hands and feet) in hospitals and pub...; and another to shoot bacteria-killing agents int...
(Date:11/25/2009)...of the Cell Death Research Laboratory in the Unive...warded the prestigious Johnson & Johnson Focused F...of brain cell damage in Parkinson,s disease. The a...support of innovation and excellence in science, w...lier this month at an event at the Hyatt Regency H...
(Date:11/24/2009)...has been prescribed by traditional healers in Braz... stomach pain to fever and flu. , Now for the fir...been able to scientifically prove the pain relievi... as Brazilian mint. , Testing this ancient South ...Graciela Rocha was able to show that when prepared...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Got a pain? -- Have a cup of Brazilian mint 2Pharmaxis Announces Placement of 2447 Million and Share Purchase Plan 12459 1Pharmaxis Announces Placement of 2447 Million and Share Purchase Plan 12459 2Orlando Dermatology Aesthetic 26 Clinical 28ODAC 29 Conference Announces Its 2010 Event 47854 1Orlando Dermatology Aesthetic 26 Clinical 28ODAC 29 Conference Announces Its 2010 Event 47854 2Pausing Hormone Therapy Doesnt Cut Mammogram Recalls 47850 1Pausing Hormone Therapy Doesnt Cut Mammogram Recalls 47850 2
...m better understand the diseases their children co...ring practical advice for preventing infections in...f Your Kids: The Complete Guide to Protecting (wit...released this week by ASM Press, is the inside sou... to health foods and home remedies. Written by in...
...ice for all types of gasoline is holding steady ar...the pump might be short-lived as research from the...ggest hurdles to the wide-scale production of fuel...ant professor of chemical and biomolecular enginee...d to make a fuel cell more efficient and less expe...
...eveloped a cancer fighting technology which uses U...ally attack tumours. , Therapeutic antibodies ha...ial but getting them to efficiently target tumour ...ofessor Colin Self and Dr Stephen Thompson from Ne...loak antibodies which can then be activated by UV-...
Other Biology News:Handbook helps parents deal with childhood infections 2Fuel cells gearing up to power auto industry 2Fuel cells gearing up to power auto industry 3UV light improving chances of fighting cancer 2
...adiochemical Purity is >95%NEN Radiolabeled Ligand...ed by the continual availability of new radiolabel...ies. PerkinElmer offers a wide range of products a...ry, including over 400 state-of-the-art radioligan...
...The benchmark for analytical performance , When...tical,performance, the Varian 810-MS delivers.,...ue* collisional interface/extraction optics minimi...race level,quantification. , Optimized sample...
...OTE: 0.9 ml per liter of urine will give a positiv...ck. ,Certification: The Donors are of US origin a...bsAg, HCV, HIV-1 & 2, Syphilis and HIV-1 Antigen b... SOLD FOR IN-VITRO DIAGNOSTIC USE ONLY IN MANUFACT...
...he LUMIstar OPTIMA is a fully automated microplate...st possible range of applications based on lumines...alactosidase, gene activities with luminescence su...) Luminescent Immunoassays Cell-based assays (cy...
Biology Products: